Whether physicians ought to interact with pharmaceutical sales representatives (reps) is a
question worthy of careful ethical analysis. The issue presents a challenge to both …

We surveyed faculty and residents from seven hospitals affiliated with three academic
internal medicine training programs about their perceptions of the informational and service …

Background Interactions between physicians and drug representatives are common, even
though research shows that physicians understand the conflict of interest between marketing …

Purpose To examine relationships between pharmaceutical representatives and obstetrician-
gynecologists and identify factors associated with self-reported reliance on representatives …

Financial relationships and business transactions between physicians and the health care
industry are common. These relationships take a variety of forms, including payments to …

Physician-industry relationships have come a long way since serious debates began after a
1990 Senate Committee on Labor and Human Resources report on the topic. On one side …

To assess primary care resident and faculty knowledge and attitudes concerning
interactions between physicians and pharmaceutical representatives (PRs) and to measure …

Background Personalized pharmaceutical marketing to physicians, including the provision
of gifts and sponsorship of educational and recreational activities, raises ethical issues. We …

Background: Although pharmaceutical sales representatives provide physicians with
information on new products, these encounters have rarely been studied in practice settings …

Marketing activities by the pharmaceutical industry directed at physicians are estimated in
the range of $13 billion annually. Others have estimated that the costs are approximately …